Allogene Therapeutics, Inc. · NASDAQ:ALLO
Tpg Gp A, LLC reported a 0% stake in Allogene Therapeutics, Inc. (Schedule 13D/A)
Event Sep 28, 2026 · Filed Sep 30, 2026
Tpg Gp A, LLC reported a 0% stake in Allogene Therapeutics, Inc., 0 shares, with active intent on Sep 28, 2026. Filed Sep 30, 2026 (Schedule 13D/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TPG GP A, LLC | 0% | 0 |
| James G. Coulter | 0% | 0 |
| Jon Winkelried | 0% | 0 |
Source
Related
- Allogene Therapeutics, Inc.
- Tpg Gp A, LLC
- Allogene Therapeutics, Inc. shareholders
- Schedule 13G · Kenneth Griffin · Nov 16, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 27, 2026
- Form 4 · Parker Geoffrey M. · Oct 23, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026